COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 1569: Articles 15681-15690  | Next

Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein
Gerdol, M.
10.1101/2021.04.17.440288 — Posted: 2021-04-19 Discussion: Onsite
Low dose inocula of SARS-CoV-2 B.1.1.7 variant initiate more robust infections in the upper respiratory tract of hamsters than earlier D614G variants
Mok, B. W.-Y., Liu, H., Lau, S.-Y., Deng, S. D., Liu, S., Tam, R. C.-Y., Ng, T. T.-L., Leung, J. S.-L., Wang, P., To, K. K.-W., Chan, J. F.-W., Chan, K.-H., Yuen, K.-Y., Siu, G. K.-H., Chen, H.
10.1101/2021.04.19.440414 — Posted: 2021-04-19
SARS-CoV-2 20I/501Y.V1 variant in the hamster model
Cochin, M., Luciani, L., Touret, F., Driouich, J. S., Petit, P.-R., Moureau, G., Baronti, C., Maes, P., Boudewijns, R., Neyts, J., de Lamballerie, X., Nougairede, A.
10.1101/2021.04.19.440435 — Posted: 2021-04-19
Live virus neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 variants following INO-4800 vaccination of ferrets
Riddell, S., Goldie, S., McAuley, A., Kuiper, M. J., Durr, P. A., Blasdell, K. R., Tachedjian, M., Druce, J. D., Smith, T. R. F., Broderick, K., Vasan, S. S.
10.1101/2021.04.17.440246 — Posted: 2021-04-19
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
Severa, M., Diotti, R. A., Etna, M. P., Rizzo, F., Fiore, S., Ricci, D., Iannetta, M., Sinigaglia, A., Lodi, A., Mancini, N., Criscuolo, E., Clementi, M., Andreoni, M., Balducci, S., Barzon, L., Stefanelli, P., Clementi, N., Coccia, E.
10.1101/2021.04.17.440278 — Posted: 2021-04-19
An Immune Cell Atlas Reveals Dynamic COVID-19 Specific Neutrophil Programming Amendable to Dexamethasone Therapy
Sinha, S., Rosin, N., Arora, R., Labit, E., Jaffer, A., Cao, L., Farias, R., Nguyen, A. P., McDonald, B., Gillrie, M., Fritzler, M. J., Yipp, B., Biernaskie, J.
10.1101/2021.04.18.440366 — Posted: 2021-04-19
Substantial Differences in SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination
Ramiro de Assis, R., Jain, A., Nakajima, R., Jasinskas, A., Khan, S., Palma, A., Parker, D. M., Chau, A., Leung, A., Christina, C., Muqolli, F., Khalil, G., Colin Escobar, J., Ventura, J., Davies, H., Albala, B., Boden-Albala, B., Schubl, S., Felgner, P. L.
10.1101/2021.04.15.440089 — Posted: 2021-04-19 Discussion: Onsite
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
Chaouat, A. E., Achdout, H., Kol, I., Berhani, O., Roi, G., Vitner, E. B., Melamed, S., Politi, B., Zahavi, E., Brizic, I., Lenac Rovis, T., Alfi, O. B., Wolf, D., Jonjic, S., Israely, T., Mandelboim, O.
10.1101/2021.04.18.440302 — Posted: 2021-04-19
Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities
Kruse, T., Benz, C., Garvanska, D. H., Lindqvist, R., Mihalic, F., Coscia, F., Inturi, R., Sayadi, A., Simonetti, L., Nilsson, E., Ali, M., Kliche, J., Moliner Morro, A., Mund, A., Andersson, E., McInerney, G. M., Mann, M., Jemth, P., Davey, N. E., Overby, A. K., Nilsson, J., Ivarsson, Y.
10.1101/2021.04.19.440086 — Posted: 2021-04-19
Fraction of COVID-19 hospitalizations and deaths attributable to chronic diseases
Reyes-Sanchez, F., Basto-Abreu, A., Torres-Alvarez, R., Canto-Osorio, F., Gonzalez-Morales, R., Dyer, D., Lopez Ridaura, R., Zaragoza Jimenez, C. A., Rivera, J. A., Barrientos-Gutierrez, T.
10.1101/2021.04.12.21255346 — Posted: 2021-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).